- Jatcorp's (JAT) Jinvigorate diabetic formula is cleared for use in clinics and hospitals in South Korean by the Ministry of Food and Drug Safety
- The product is used as a food supplement to support the nutritional needs of people with diabetes
- Jatcorp expects to receive its first order from its South Korean distributor before the end of October
- JAT Managing Director Wilton Yao said the approval secures a "distinctive position" for JAT’s brand in South Korea
Read the Full Article on The Market Herald here
Jatcorp’s (ASX:JAT) diabetic formula approved by South Korean Govt.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.06M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20091 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 20174 | 1 |
View Market Depth
| Last trade - 10.00am 17/09/2025 (20 minute delay) ? |
| JAT (ASX) Chart |
Day chart unavailable